Home » Stocks » Eton Pharmaceuticals

Eton Pharmaceuticals, Inc. (ETON)

Stock Price: $7.60 USD -0.04 (-0.52%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
After-hours: $7.66 +0.06 (0.79%) Oct 26, 7:05 PM

Stock Price Chart

Key Info

Market Cap 183.74M
Revenue (ttm) 578,000
Net Income (ttm) -21.44M
Shares Out 24.18M
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $7.60
Previous Close $7.64
Change ($) -0.04
Change (%) -0.52%
Day's Open 7.60
Day's Range 7.43 - 7.71
Day's Volume 184,811
52-Week Range 2.50 - 9.12

More Stats

Market Cap 183.74M
Enterprise Value 178.42M
Earnings Date (est) Nov 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 24.18M
Float 16.34M
EPS (basic) -1.16
EPS (diluted) -1.14
FCF / Share -0.82
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 906,732
Short Ratio 1.21
Short % of Float 5.55%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 317.89
PB Ratio 26.83
Revenue 578,000
Operating Income -21.12M
Net Income -21.44M
Free Cash Flow -17.20M
Net Cash 5.32M
Net Cash / Share 0.22
Gross Margin 87.54%
Operating Margin -3,653.46%
Profit Margin -3,709.30%
FCF Margin -2,976.30%
ROA -80.47%
ROE -180.70%
ROIC -418.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(110.53% upside)
Current: $7.60
Target: 16.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit0.51-
Operating Income-18.60-10.32
Net Income-18.32-12.74
Shares Outstanding17.766.42
Earnings Per Share-1.03-5.80
Operating Cash Flow-18.03-8.15
Capital Expenditures-1.10-0.24
Free Cash Flow-19.12-8.38
Cash & Equivalents12.0726.74
Total Debt4.56-
Net Cash / Debt7.5126.74
Book Value10.5526.30
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Eton Pharmaceuticals, Inc.
Country United States
Employees 17
CEO Sean E. Brynjelsen

Stock Information

Ticker Symbol ETON
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ETON
IPO Date November 13, 2018


Eton Pharmaceuticals, a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.